Key #1 For Successful ePRO Selection In Your Ophthalmology Clinical Trial: Ensure The ePRO Answers The Intended Clinical Endpoint

Source: Kayentis

PROs have become a vital part of modern ophthalmology with an increasing focus on PROs within high-quality ophthalmic trials. International organizations are now significant contributors to the development, access, and guidance for the best use of PROs.

Some of the benefits of a PRO or ePRO are that they can be used to evaluate a primary endpoint, a secondary endpoint, and an exploratory endpoint. Watch the available video to hear about the importance of carefully selecting the measure that will answer the intended endpoint, whether it be primary, secondary, or exploratory in ophthalmic trials while also factoring in the patients’ capabilities.

For more information on Clinical Technologies, visit the Clinical Leader page.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader